Technology
-
Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China PatientsDetails
SHANGHAI,Dec. 18,2024-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm
-
Digital Realty Empowers Turing's Gaggle Cluster with Optimal Data Center Environment to Fast-Track Full Drive Automation by AIDetails
Robust and flexible platform supporting large-scale GPU cluster for AI-driven autonomous vehicles boosts Turing\'s speed-to-market by 75%
-
GRAMMY-AWARD WINNING DJ BLACK COFFEE IS COMING BACK TO SINGAPORE ON JANUARY 11, 2025Details
South African DJ and Global Music Icon to Bring his Signature Afro-House Sound to 27 Pasir Panjang,presented by Collective Minds
-
Neurizon Files IND Application to Support HEALEY ALS Platform TrialDetails
Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001
-
China Matters' Feature: How History Uncovers the CultureDetails
HANGZHOU,China,Dec. 12,2024-- In the heart ofHangzhou,Liangzhu Ancient City,which boasts rich cultural heritage,stands as a testament to a sophisticated 5,000-year-old civilization. At the 2nd Liangzh
-
Iridium Transforms Satellite IoT with the Launch of Revolutionary Iridium Certus 9704 ModuleDetails
The new module is supported by the Iridium Certus 9704 Development Kit,and is ideal for data,audio messages and image transfers,while positioning companies as more future ready in anticipation of Sat
-
Fujitsu develops video analytics AI agent to support safe, secure, and efficient frontline workplacesDetails
New technology achieves world-leading accuracy while significantly extending video duration processing capability
-
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast CancerDetails
ADELA,an international phase III study being conducted across multiple countries,combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations,aiming to delay dis
-
MMA Global APAC and FairPrice Group (FPG) unveiled The Retail Media LabDetails
SINGAPORE,Dec. 12,2024-- MMA Global APAC and FairPriceGroup (FPG) today unveiled The Retail Media Lab,an innovative program that will enable marketers to measure and demonstrate the efficacy and effec
-
2024 SABCS｜Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver MetastasisDetails
YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme